Re: Debt

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Debt

in response to

Re: Debt

narmac

posted on Apr 04, 2022 10:39AM

narmac, got it but as far as I am concerned when all the shares are counted what is offered per share (on a fully diluted basis) in a buy-out is what counts. And if management gets the best possible price on a per-share basis for their self-interest we're right there on their coattails.